How much funding has Ilya Pharma raised?

Ilya Pharma has raised $13.7M in total funding, most recently a Series B round.

Who are Ilya Pharma's investors?

Ilya Pharma's investors include European Innovation Council Fund.

When was Ilya Pharma founded?

Ilya Pharma was founded in 2016.

Where is Ilya Pharma headquartered?

Ilya Pharma is headquartered in Uppsala, Sweden.

What industry is Ilya Pharma in?

Ilya Pharma operates in Biotech, Healthcare.

How many employees does Ilya Pharma have?

Ilya Pharma has 11-50 employees.

Ilya Pharma

Uppsala, Sweden · Founded 2016 · $13.7M raised

Biotech

Healthcare

Headquarters: Uppsala
Employees: 11–50
Founded: 2016
Business Model: B2B

Website: ilyapharma.se
Total Funding: $13.7M
Last Round: $9.8M Series BMar 2022
Rounds: 3

About

Ilya Pharma is a Swedish biopharmaceutical company, founded in 2016 out of research at Uppsala University, developing next-generation local-acting immunotherapies and biologic drugs to treat wounds in skin and mucosa. Its lead program, ILP100, uses engineered lactic acid bacteria to deliver the therapeutic protein CXCL12 directly to wound sites to accelerate healing, and has advanced through Swedish Medical Products Agency-approved clinical trials.

Summary

Ilya Pharma is a Biotech company based in Uppsala, Sweden, founded in 2016. It has raised $13.7M in total across 3 rounds, most recently a $9.8M Series B round in Mar 2022. Investors include European Innovation Council Fund.